Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma.
暂无分享,去创建一个
E. Kerwin | W. Busse | S. Holgate | Y. Chon | Shao-Lee Lin | Joseph H. Lin | J. Feng
[1] E. Kerwin,et al. A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab (AMG 827) in Subjects with Moderate to Severe Asthma , 2013 .
[2] R. Alizadehfar,et al. Validation of the Cork-Southampton Food Challenge Outcome Calculator in a Canadian sample. , 2013, The Journal of allergy and clinical immunology.
[3] Q. Hamid,et al. Autocrine-regulated airway smooth muscle cell migration is dependent on IL-17-induced growth-related oncogenes. , 2012, The Journal of allergy and clinical immunology.
[4] D. Salinger,et al. Anti-IL-17 receptor antibody AMG 827 leads to rapid clinical response in subjects with moderate to severe psoriasis: results from a phase I, randomized, placebo-controlled trial. , 2012, The Journal of investigative dermatology.
[5] S. Targan,et al. Mo2083 A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of AMG 827 in Subjects With Moderate to Severe Crohn's Disease , 2012 .
[6] S. Holgate. Trials and tribulations in identifying new biologic treatments for asthma. , 2012, Trends in immunology.
[7] J. Ortonne,et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis. , 2012, The New England journal of medicine.
[8] D. Sheppard,et al. IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction , 2012, Nature Medicine.
[9] C. Chung,et al. Phosphoinositide 3-kinase &dgr; inhibitor suppresses interleukin-17 expression in a murine asthma model , 2010, European Respiratory Journal.
[10] D. Curran‐Everett,et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. , 2010, American journal of respiratory and critical care medicine.
[11] S. Gaffen. Structure and signalling in the IL-17 receptor family , 2009, Nature Reviews Immunology.
[12] C. Lemière,et al. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. , 2009, The Journal of allergy and clinical immunology.
[13] P. Giavina-Bianchi,et al. Esophageal Candidiasis—An Adverse Effect of Inhaled Corticosteroids Therapy , 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.
[14] E. Rickel,et al. Identification of Functional Roles for Both IL-17RB and IL-17RA in Mediating IL-25-Induced Activities , 2008, The Journal of Immunology.
[15] I. Ghiran,et al. Airway Eosinophils: Allergic Inflammation Recruited Professional Antigen-Presenting Cells1 , 2007, The Journal of Immunology.
[16] S. Peters,et al. Real-world Evaluation of Asthma Control and Treatment (REACT): findings from a national Web-based survey. , 2007, The Journal of allergy and clinical immunology.
[17] B. Ryffel,et al. Interleukin-17 is a negative regulator of established allergic asthma , 2006, The Journal of experimental medicine.
[18] W. Busse,et al. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study , 2006, BMC pulmonary medicine.
[19] Linda Abetz,et al. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. , 2006, Respiratory medicine.
[20] J. Lötvall,et al. Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. , 2005, American journal of respiratory cell and molecular biology.
[21] R. Pauwels,et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. , 2004, American journal of respiratory and critical care medicine.
[22] T. Shimoda,et al. Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. , 2003, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[23] L. Boulet,et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. , 2003, The Journal of allergy and clinical immunology.
[24] W. Pierzchała,et al. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. , 2003, Respiratory medicine.
[25] Q. Hamid,et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. , 2001, The Journal of allergy and clinical immunology.
[26] J. Lötvall,et al. Neutrophil recruitment by interleukin-17 into rat airways in vivo. Role of tachykinins. , 1999, American journal of respiratory and critical care medicine.